KRISTINA ARKOUB: Open Payments
NPI 1659051407 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 13 payments from 8 companies in 2025. Trend: 2023 $157 · 2024 $3,661 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $139 |
| UROGEN PHARMA, INC. | 2 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| TOLMAR, INC. | 3 | $53 |
| Exact Sciences Corporation | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| IMMUNITYBIO, INC. | 1 | $20 |
| Laborie Medical Technologies Corp. | 1 | $20 |
Products named: Axonics, JELMYTO, GEMTESA, JATENZO, The Cologuard Plus Collection Kit, PLUVICTO, ANKTIVA, ELIGARD.
Industry payments across MI — which companies pay providers there.
